In addition, the IDH mutation status was also balanced between the training and validation datasets (p = 0.918), and in accordance with the 2016 WHO classification of CNS tumors, all 1p/19q co-deleted tumors harbored IDH1 or IDH2 mutations. This evidence concerns the gene IDH1 and central nervous system neoplasm.